Clonidine Hydrochloride Tablet, Extended Release
Product Images NDC 0228-4241

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Clonidine Hydrochloride (NDC 0228-4241). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Clonidine Hydrochloride 0.1 mg extended release tablets in a white and blue blister card. Each card contains 30 tablets in 3 rows of 10. The brand and active ingredient name appear at the top, with strength and dosage form below. Manufactured by Actavis Pharma, Inc.*

FDA Label Image

Image 2

Chemical structure of Clonidine Hydrochloride showing its molecular formula and weight. The diagram includes the arrangement of atoms and bonds, depicting the compound labeled with chlorine (Cl), nitrogen (N), and hydrogen (H) atoms.*

FDA Label Image

Image 3

A line graph showing mean concentration (pg/mL) of Clonidine Hydrochloride over time (hours) for three conditions: Extended-Release Fasted, Extended-Release Fed, and Immediate-Release Fasted. Concentration peaks quickly for Immediate-Release and more gradually for Extended-Release formulations, with levels declining over 48 hours.*

FDA Label Image

Image 4

A Kaplan-Meier survival curve illustrating the estimated proportion of patients with treatment failure over days from randomization. The graph compares two groups: Clonidine Hydrochloride Extended-Release (red solid line) and Placebo (black dashed line). The vertical axis shows the proportion of patients with treatment failure (0 to 1), while the horizontal axis represents days from randomization to treatment failure (0 to 220). Censored data points are marked with plus signs on both curves.*

FDA Label Image

Image 5

Clonidine Hydrochloride 0.1 mg extended-release oral tablets packaging. The blister card contains 10 round light yellow tablets with a central break line. The label displays the brand and generic name, dosage strength, and manufacturer Actavis Pharma, Inc.*

FDA Label Image

Image 6

Clonidine Hydrochloride 0.1 mg Extended-Release Tablets label for oral use, displaying the product name, strength, dosage form, and packaging size of 60 tablets. The label includes directions to dispense a separate patient information leaflet, manufacturer Actavis Elizabeth LLC, and distributor Actavis Pharma, Inc. The label features a barcode and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.